Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 4

1(20.0%)

Phase 1

1(20.0%)

5Total

N/A(3)

Phase 4(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07135791Recruiting

Monitoring Fatigue In Daily Life In Adults With Cerebral Palsy or Acquired Brain Injury

Role: collaborator

NCT04250454Not ApplicableRecruiting

Early Intervention in Infants With Cerebral Palsy

Role: collaborator

NCT03648658Phase 4Recruiting

Paracetamol Study in Patients With Low Muscle Mass

Role: collaborator

NCT05336487Not ApplicableUnknown

Physical Activity, Sports and Health in Adults With Intellectual Disabilities

Role: collaborator

NCT04614207Completed

Cerebral Palsy & Predictors of Physical Activity

Role: collaborator

NCT03770741Not ApplicableCompleted

Safeguarding the Brain of Our Smallest Infants Phase III

Role: collaborator

NCT04207632Unknown

Quantifying Muscle Tone in Patients With Brain Injury - a Feasibility Study

Role: collaborator

NCT01530360Phase 1Completed

Cerebral Oxygenation to Guide Medical Interventions in Extremely Preterm Infants

Role: collaborator

All 8 trials loaded